Is BrainCo profitable in 2026?

No verified profitability figures exist. Pitchbook data cited BrainCo as 'generating revenue' around its January 2026 RMB 2 billion financing round, but no audited revenue or profit figures have been disclosed. The company is still private and pursuing a Hong Kong IPO filed confidentially in January 2026.

Could AI replace BrainCo's core technology?

BrainCo's EEG/EMG decoding layer is itself an AI model, exposing it to commoditization. OpenAI backed rival Merge Labs with a reported $250M investment in 2026, and Apple announced a BCI input protocol in May 2025, both threatening to absorb BrainCo's decoding advantage into broader platforms.

Who is BrainCo's biggest competitor?

Neuralink is the dominant rival, with private secondary valuations reaching $40 to 47 billion by mid-2026 versus BrainCo's sub $1.3B valuation as of August 2025. Synchron and OpenAI-backed Merge Labs are also converging on BrainCo's brain-computer interface space with far more capital.

BrainCo is privately held, founded in 2015 by Bicheng Han, a Harvard PhD student. It relocated HQ to Hangzhou in 2018. Backers include China Electronics Corp since 2017, and a January 2026 RMB 2 billion round co-led by IDG Capital and Walden International, founded by Intel CEO Lip-Bu Tan.

Is BrainCo going public?

BrainCo filed confidentially for a Hong Kong Stock Exchange IPO in January 2026, advised by CICC and UBS, targeting a raise of several hundred million dollars. As of July 2026 the IPO status remains unresolved amid scrutiny from the Hunterbrook investigation into its funding and data practices.

What is BrainCo's current valuation?

BrainCo raised at a valuation exceeding $1.3 billion in August 2025 ahead of a potential IPO, and completed a further RMB 2 billion (about $280 to 287 million) financing round in January 2026 co-led by IDG Capital and Walden International.

China · China

BrainCo

Maker of EEG headbands, bionic hands, and brain-controlled robot systems.

Losing its protection

Assessed 29 July 2026 · Evidence as of 29 July 2026

The structural protection is eroding.

On the recordSince 29 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Outcome of confidentially filed Hong Kong IPO (CICC/UBS advised)

The call

BrainCo ships real hardware and holds FDA clearance, but faces AI commoditization risk and an IPO clouded by funding and data-consent claims.

BrainCo builds devices that use brain signals (EEG and EMG) to control prosthetic hands and has received FDA approval for one product sold in China. The technology itself is not that hard to copy because companies like Apple, Google, OpenAI-backed Merge Labs, and Neuralink are all investing heavily in similar brain-reading systems, and these larger tech firms can throw more money and talent at the problem. What matters most right now is whether BrainCo can survive the damage from reports about how it raised money and collected user data, and whether its planned Hong Kong stock offering actually happens.

Why

AI pressure: OpenAI-backed Merge Labs. Merge Labs and Neuralink could commoditize the EEG/EMG decoding software that is BrainCo's core product. Could AI do the core job? Yes, likely.

Bigger players: Apple and Google (BCI platform layer). Apple's 2025 BCI protocol could let phones own the brain-signal interface, cutting BrainCo out of the stack. Could a giant copy it? Probably.

What protects it. FDA clearance on its bionic hand plus China state-linked funding and distribution give it footing rivals lack.

What would change this call

BrainCo's Hong Kong IPO prices, stalls, or is withdrawn. Shows whether investors accept its valuation and sanctions-linked funding disclosures.
Regulatory action follows the Hunterbrook/Torre data-consent investigation. Would show real legal or reputational damage rather than just allegations.
Apple or Google publish BCI standards that include or exclude BrainCo routing. Shows whether platform giants treat BrainCo as a partner or bypass it entirely.

Key numbers

$1.3B+ valuation reached (2025-08)
RMB 2B (~$280M) raised from IDG, Walden (2026-01)
FDA-cleared bionic hand shipped (2022-11)

Named risks

Sanctions-linked backer China Electronics Corp threatens IPO due diligence and Western dealings. Severity: high
Hunterbrook allegations of non-consensual brain-data collection from athletes and schoolchildren unresolved. Severity: high
Hong Kong IPO timing and pricing remain unresolved as of July 2026. Severity: medium
Revenue and headcount figures are unverified and inconsistent across sources. Severity: medium
Frontier labs and platform giants (Apple, OpenAI-backed Merge Labs) may commoditize core decoding tech. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Neuralink	gaining on	Private secondary valuation reached $40-47B by mid-2026 vs BrainCo's $1.3B (Aug 2025)
Merge Labs (OpenAI-backed)	gaining on	Received reported $250M OpenAI investment in 2026, threatening decoding-layer commoditization
Synchron	contesting	Demonstrated iPad control via implanted BCI in August 2025
Apple	contesting	Announced BCI Human Interface Device input protocol in May 2025

Questions people ask

Is BrainCo profitable in 2026?: No verified profitability figures exist. Pitchbook data cited BrainCo as 'generating revenue' around its January 2026 RMB 2 billion financing round, but no audited revenue or profit figures have been disclosed. The company is still private and pursuing a Hong Kong IPO filed confidentially in January 2026.
Could AI replace BrainCo's core technology?: BrainCo's EEG/EMG decoding layer is itself an AI model, exposing it to commoditization. OpenAI backed rival Merge Labs with a reported $250M investment in 2026, and Apple announced a BCI input protocol in May 2025, both threatening to absorb BrainCo's decoding advantage into broader platforms.
Who is BrainCo's biggest competitor?: Neuralink is the dominant rival, with private secondary valuations reaching $40 to 47 billion by mid-2026 versus BrainCo's sub $1.3B valuation as of August 2025. Synchron and OpenAI-backed Merge Labs are also converging on BrainCo's brain-computer interface space with far more capital.
Who owns BrainCo?: BrainCo is privately held, founded in 2015 by Bicheng Han, a Harvard PhD student. It relocated HQ to Hangzhou in 2018. Backers include China Electronics Corp since 2017, and a January 2026 RMB 2 billion round co-led by IDG Capital and Walden International, founded by Intel CEO Lip-Bu Tan.
Is BrainCo going public?: BrainCo filed confidentially for a Hong Kong Stock Exchange IPO in January 2026, advised by CICC and UBS, targeting a raise of several hundred million dollars. As of July 2026 the IPO status remains unresolved amid scrutiny from the Hunterbrook investigation into its funding and data practices.
What is BrainCo's current valuation?: BrainCo raised at a valuation exceeding $1.3 billion in August 2025 ahead of a potential IPO, and completed a further RMB 2 billion (about $280 to 287 million) financing round in January 2026 co-led by IDG Capital and Walden International.

Timeline

2026-07-17Unveiled Neuro-Embodied-AI brain-to-robot platform at WAIC Shanghai
2026-05Partnered with Hong Kong Polytechnic University on 60-amputee prosthetics pilot
2026-04-09Launched Revo3 dexterous hand with 21 degrees of freedom
2026-01-12Filed confidentially for Hong Kong IPO via CICC and UBS
2026-01Completed RMB 2 billion financing round led by IDG Capital and Walden International
2025-09-20Denied Hunterbrook military-funding and data-collection allegations
2025-09-16Hunterbrook Media published investigation into funding ties and brain-data collection
2025-09Opened Asia-Pacific HQ at Hong Kong Cyberport
2025-08Raised at valuation exceeding $1.3 billion ahead of IPO plans
2022-11BrainRobotics bionic hand received FDA clearance

Revision history

29 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Meituan Shein Group Xiaomi Corporation